In the last trading session, 1.39 million Aptevo Therapeutics Inc (NASDAQ:APVO) shares changed hands as the company’s beta touched 5.26. With the company’s per share price at $1.39 changed hands at -$0.1 or -6.71% during last session, the market valuation stood at $2.02M. APVO’s last price was a discount, traded about -12863.31% off its 52-week high of $180.19. The share price had its 52-week low at $0.94, which suggests the last value was 32.37% up since then. When we look at Aptevo Therapeutics Inc’s average trading volume, we note the 10-day average is 11.13 million shares, with the 3-month average coming to 1.82 million.
Aptevo Therapeutics Inc (NASDAQ:APVO) trade information
Instantly APVO was in red as seen at the end of in last trading. With action 19.83%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -67.75%, with the 5-day performance at 19.83% in the green. However, in the 30-day time frame, Aptevo Therapeutics Inc (NASDAQ:APVO) is -45.28% down. Looking at the short shares, we see there were 0.12 million shares sold at short interest cover period of 2.61 days.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 80.96%. The 2025 estimates are for Aptevo Therapeutics Inc earnings to increase by 81.87%, but the outlook for the next 5-year period is at 51.40% per year.
APVO Dividends
Aptevo Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Feb-13.
Aptevo Therapeutics Inc (NASDAQ:APVO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.01% of Aptevo Therapeutics Inc shares while 4.85% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.85%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 1.16 shares estimated at $1609.0 under it, the former controlled 0.08% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.05% of the shares, roughly 668.0 shares worth around $928.0.
